Literature DB >> 14737001

In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.

Pratibha V Nerurkar1, Klaus Dragull, Chung-Shih Tang.   

Abstract

Kava herbal supplements have been recently associated with acute hepatotoxicity, leading to the ban of kava products in approximately a dozen countries around the world. It is suspected that some alkaloids from aerial kava may have contributed to the problem. Traditionally, Pacific Islanders use primarily the underground parts of the shrub to prepare the kava beverage. However, some kava herbal supplements may contain ingredients from aerial stem peelings. The aim of this study was to test the in vitro effects of a major kava alkaloid, pipermethystine (PM), found mostly in leaves and stem peelings, and kavalactones such as 7,8-dihydromethysticin (DHM) and desmethoxyyangonin (DMY), which are abundant in the roots. Exposure of human hepatoma cells, HepG2, to 100 microM PM caused 90% loss in cell viability within 24 h, while 50 microM caused 65% cell death. Similar concentrations of kavalactones did not affect cell viability for up to 8 days of treatment. Mechanistic studies indicate that, in contrast to kavalactones, PM significantly decreased cellular ATP levels, mitochondrial membrane potential, and induced apoptosis as measured by the release of caspase-3 after 24 h of treatment. These observations suggest that PM, rather than kavalactones, is capable of causing cell death, probably in part by disrupting mitochondrial function. Thus, PM may contribute to rare but severe hepatotoxic reactions to kava.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14737001     DOI: 10.1093/toxsci/kfh067

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  17 in total

1.  Toxicological evaluation of methanol leaves extract of Vernonia bipontini Vatke in blood, liver and kidney tissues of mice.

Authors:  Mebratu Alebachew; Yamrot Kinfu; Eyasu Makonnen; Yonas Bekuretsion; Kelbesa Urga; Mekbeb Afework
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 2.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

3.  Fruit secondary compounds mediate the retention time of seeds in the guts of Neotropical fruit bats.

Authors:  Justin W Baldwin; Susan R Whitehead
Journal:  Oecologia       Date:  2014-09-28       Impact factor: 3.225

Review 4.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

5.  Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Authors:  Yan Li; Hu Mei; Qiangen Wu; Suhui Zhang; Jia-Long Fang; Leming Shi; Lei Guo
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

6.  Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.

Authors:  Ping Zhou; Shimon Gross; Ji-Hua Liu; Bo-Yang Yu; Ling-Ling Feng; Jan Nolta; Vijay Sharma; David Piwnica-Worms; Samuel X Qiu
Journal:  FASEB J       Date:  2010-08-09       Impact factor: 5.191

7.  Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.

Authors:  Pratibha V Nerurkar; Yun Kyung Lee; Ellen H Linden; Steven Lim; Laurel Pearson; Jennifer Frank; Vivek R Nerurkar
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

8.  Adult adipose-derived stem cell attachment to biomaterials.

Authors:  Heather L Prichard; William M Reichert; Bruce Klitzman
Journal:  Biomaterials       Date:  2006-10-30       Impact factor: 12.479

9.  The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.

Authors:  J Sarris; D J Kavanagh; G Byrne; K M Bone; J Adams; G Deed
Journal:  Psychopharmacology (Berl)       Date:  2009-05-09       Impact factor: 4.530

Review 10.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.